The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
The ethos behind TLJ is built on learning. Learning never stops and emerging stars, expert professionals and opinion leaders all need to keep learning to stay on top of their discipline.
TLJ 2.0 focused on providing value and producing concrete outcomes for transplantation professionals. By adopting a comprehensive, virtual, 360 experience, TLJ 2.0 enables participants to grow their knowledge and develop collaborations on a range of topics in transplantation.
With the aim of fostering productive discussion and interaction before and after the event, TLJ 2.0 featured a series of complimentary preparatory webinars, workstream activity reports and interactive focus sessions developed by ESOT’s Sections and Committees – providing value to all audiences. Topics of discussion were carefully crafted based on an extensive consultation and represented the focal points of each workstream. These topics were managed by leaders in the field, who connected peers and mentors alike.
Workstreams are at the core of TLJ 2.0 and they will develop a series of consensus papers aimed for publication in ESOT’s journal, Transplant International.
This consensus workshop will focus on endpoints solely on “how to define successful kidney transplantation”. This focuses on the innovative organ sources, like xenotransplants, 3D printed organs, lab grown organs, currently not used resuscitated organs using innovative perfusion techniques etc.
Group members: Georg Böhmig (Austria), Erik Berglund (Sweden), Emanuele Cozzi (Italy), Martin Hoogduijn (the Netherlands), Ina Jochmans (Belgium), James Neuberger (UK), Colin White (Ireland)
Maarten NaesensRead ProfileThis workstream focuses on describing the state of the art of the prevention and treatment of CMV infection in solid organ transplant recipients.
Leader: Paolo Grossi
Group members: Luciano Potena (Italy), Jose Maria Aguado (Spain), Nassim Kamar (France), Pilar Perez Romero (Spain)
Forum moderator: Maria Simonenko and Cristina Rovelli
Kindly supported by an unrestricted grant from MSD.
The aim of this workgroup is to establish a consensus on key questions concerning cancer in solid organ transplant recipients namely, what are the changes of immunosuppressive therapy that can currently be recommended in transplant recipients with skin and non-skin cancers.
Leader: Umberto Maggiore
Group members: Rachel Hellemans (Belgium), Sylvain Choquet (France)
Forum moderators: Ilaria Galdolfini and Alessandra Palmisano
This workstream aims to provide an evidence based answer to the following question: Should NRP become standard of care in DCD donation?
Leader: Ina Jochmans
Group members: Amelia Hessheimer (Spain), Arne Neyrinck (Belgium), John Dark (UK), Chris Watson (UK), Diederik Kimenai (The Netherlands), David Paredes Zapata (Spain).
Forum moderator: Maria Irene Bellini
Donation and transplantation is a going-on discipline. Organ donors and recipients are time by time more complex from the medical perspective and we must guarantee that the transplant of this non-standard and non extended criteria donor is safe.
Leaders: Giuseppe Feltrin and Nuria Masnou
Group members: Željka Gavranović, (Croatia), Paolo Grossi (Italy), Aurora Navarro (Spain) and Peter Veitch (UK)
Forum moderator: Omar Taco
This workstream focuses on discussing the potential recipients with otherwise suitable donors who are relegated to the ever-expanding deceased-donor waiting list because of preformed human leukocyte antigen (HLA) antibodies (HLA sensitization) which may be acquired via pregnancy, transfusion, and/or prior transplant.
Leader: Nizam Mamode
Group members: Oriol Bestard (Spain), Christophe Legendre (France), Maarten Naesens (Belgium), Lucrezia Furian (Italy), Sian Griffin (UK), Frans Claas (The Netherlands)
Forum moderator: Edoardo Melilli
Kindly supported by an unrestricted grant from Hansa Biopharma
Collaboration between members/countries of the ESOT community to analyse data retrospectively and to create a (flexible and regularly updated) guideline document to support the individuals (patients and clinicians) within the Transplant community in times of a pandemic.
Leader: Vassilios Papalois
Group members: Liset Pengel (UK), Luca Segantini (Italy), Maria Irene Bellini (UK), Natalie Vallant (UK), Luciano Potena (Italy), Olivier Thaunat (France), Alexandre Loupy (France), Annemarie Weissenbacher (Austria), Lucrezia Furian (Italy), Wojtek Polak (The Netherlands), Ivan Knezevic (Slovenia), Julian de la Torre-Cisneros (Spain), Ellisiv Stifoss-Hansen (Norway), Peter Carstedt (Sweden), Katja
Kotsch (Germany), Nina Pilat-Michalek (Austria)
Forum moderator: Maria Irene Bellini and Vassilios Papalois
Kindly supported by an unrestricted grant from industry.
The introduction of a Patient Learning Workstream reflected ESOT’s commitment to creating mutual understanding and collaborative opportunities for Transplant Donor Coordinators, Allied Healthcare Professionals, Ethical, Legal and Psychosocial Aspects of Organ Transplantation and the European Transplant Patient Organisation (ETPO) Alliance. These activities focused on what it means to be an organ recipient – creating a platform for learning and collaboration on patients’ main concerns and how we can deal with them.
Attendees were also given the opportunity to take part in our Speciality Sessions, joining global discussions on the most recent developments in the respective areas of specialisation, including combined paediatric transplantation (EKITA), heart and lung transplantation (ECTTA), and issues concerning organ regeneration, innate immunity, and tolerance (BSC, ECTORS, VCA).
What are the main issues and considerations with regard to combined transplants from the surgical, medical and ethical point of view.
EKITA Board members: Robert Langer (Austria), Diederik Kimenai (The Netherlands), Fritz Diekmann (Spain), Maria Irene Bellini (UK), Lucrezia Furian (Italy), Karine Hadaya (Switzerland), Jelena Stojanovic (UK), Baris Akin (Turkey), Aiko de Vries (The Netherlands), Dimitrios Moutzouris (UK), Maarten Naesens (Belgium)
In two sessions we will discuss some most current topics with regards to cardiothoracic transplantation. Follow our debate on machine perfusion and the session dedicated to managing outcomes of cardiothoracic transplantation.
ECTTA Board members: Ivan Knezevic (Slovenia), Robin Vos (Belgium), Cristiano Amarelli (Italy), Massimo Boffini (Italy), Michiel Erasmus (Netherlands), Arne Neyrinck (Belgium), Johann Nielson (Sweden), Andreas Zuckermann (Austria).
Join the BSC symposium for the latest updates on regeneration, metabolism and innate immunity in transplantation research. We want to provide you with selected highlights and cutting edge innovations in transplant medicine with special regard to basic immunology, organ regeneration and vascularized composite tissue transplantation.
Scientific Organisers
Katja Kotsch (BSC)
Nina Pilat (BSC)
Martin Hoogduijn (ECTORS)
Gerald Brandacher (VCA)
In light of the findings from the event, workgroups are developing a series of consensus papers aimed for publications in Transplant International and further dissemination and interaction will be achieved by interactive materials hosted on Transplant Live, the ESOT e-learning platform.
13 Oct - 13 Oct 2022 | online
Stefan Schneeberger
Ina Jochmans
Giuseppe Feltrin
Nuria Masnou Burralló
Vassilios Papalois
Anna Forsberg
Nichon Jansen
Hannah Maple
Emma Massey
David Paredes-Zapata
